• A1M 2.44 %
  • buy 0.92
  • sell 0.92
  • latest 0.92

ROSgard™ – the first drug based on the protein A1M

Acute kidney injuries and pre-eclampsia affect millions of people each year and are conditions for which there is currently no curative treatment. With ROSgard™ it would be possible to give the body an extra boost of the protein A1M and thereby treat these conditions.

A1M Pharma AB | Scheelevägen 22 | 223 63 Lund
+46 46 286 50 30 | info@a1m.se
Legal disclaimer | © Copyright - A1M